Publications 2021

Bjerkreim BA, Hammerstad SS, Gulseth HL, Berg TJ, Lee-Odegard S, Rangberg A, Jonassen CM, Budge H, Morris D, Law J, Symonds M, Eriksen EF (2021)
Effect of Liothyronine Treatment on Dermal Temperature and Activation of Brown Adipose Tissue in Female Hypothyroid Patients: A Randomized Crossover Study
Front. Endocrinol., 12, 785175
DOI 10.3389/fendo.2021.785175

Nokleby K, Berg TJ, Mdala I, Tran AT, Bakke A, Gjelsvik B, Claudi T, Cooper JG, Lovaas KF, Thue G, Sandberg S, Jenum AK (2021)
Variation between general practitioners in type 2 diabetes processes of care
Prim. Care Diabetes, 15 (3), 495-501
DOI 10.1016/j.pcd.2020.11.018

Opstad TB, Berg TJ, Holte KB, Arnesen H, Solheim S, Seljeflot I (2021)
Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long-term survivors of type 1 diabetes: A Dialong substudy
J. Diabetes Investig., 12 (7), 1183-1192
DOI 10.1111/jdi.13470

Sveen KA, Holte KB, Svanteson M, Hanssen KF, Nilsson J, Bengtsson E, Berg TJ (2021)
Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
Diabetes Care, 44 (6), 1402-1409
DOI 10.2337/dc20-2089

Publications 2020

Holte KB, Svanteson M, Hanssen KF, Sveen KA, Seljeflot I, Solheim S, Sell DR, Monnier VM, Berg TJ (2020)
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
PLoS One, 15 (5), e0233174
DOI 10.1371/journal.pone.0233174

Jain R, Ozgumus T, Jensen TM, du Plessis E, Keindl M, Moller CL, Falhammar H, Nystrom T, Catrina SB, Jorneskog G, Jessen LE, Forsblom C, Haukka JK, Groop PH, Rossing P, Groop L, Eliasson M, Eliasson B, Brismar K, Al-Majdoub M, Nilsson PM, Taskinen MR, Ferrannini E, Spegel P, Berg TJ et al. (2020)
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes
Sci Rep, 10 (1), 11561
DOI 10.1038/s41598-020-68130-y

Keindl M, Fedotkina O, du Plessis E, Jain R, Bergum B, Jensen TM, Moller CL, Falhammar H, Nystrom T, Catrina SB, Jorneskog G, Groop L, Eliasson M, Eliasson B, Brismar K, Nilsson PM, Berg TJ, Appel S, Lyssenko V (2020)
Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms
Front. Endocrinol., 11, 575469
DOI 10.3389/fendo.2020.575469

Opstad TB, Kalstad AA, Holte KB, Berg TJ, Solheim S, Arnesen H, Seljeflot I (2020)
Shorter Leukocyte Telomere Lengths in Healthy Relatives of Patients with Coronary Heart Disease
Rejuv. Res., 23 (4), 324-332
DOI 10.1089/rej.2019.2258

Slatsve KB, Claudi T, Lappegard KT, Jenum AK, Larsen M, Cooper JG, Sandberg S, Berg TJ (2020)
The total prevalence of diagnosed diabetes and the quality of diabetes care for the adult population in Salten, Norway
Scand. J. Public Health, 1403494820951004
DOI 10.1177/1403494820951004

Tollanes MC, Jenum AK, Berg TJ, Lovaas KF, Cooper JG, Sandberg S (2020)
Availability and analytical quality of hemoglobin A(1c) point-of-care testing in general practitioners' offices are associated with better glycemic control in type 2 diabetes
Clin. Chem. Lab. Med., 58 (8), 1349-1356
DOI 10.1515/cclm-2020-0026

Publications 2019

Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ (2019)
Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
J. Diabetes Complications, 33 (5), 383-389
DOI 10.1016/j.jdiacomp.2019.01.006

Svanteson M, Holte KB, Haig Y, Klow NE, Berg TJ (2019)
Coronary plaque characteristics and epicardial fat tissue in long term survivors of type 1 diabetes identified by coronary computed tomography angiography
Cardiovasc. Diabetol., 18, 58
DOI 10.1186/s12933-019-0861-x

Tran AT, Berg TJ, Gjelsvik B, Mdala I, Thue G, Cooper JG, Nokleby K, Claudi T, Bakke A, Sandberg S, Jenum AK (2019)
Ethnic and gender differences in the management of type 2 diabetes: a cross-sectional study from Norwegian general practice
BMC Health Serv. Res., 19 (1), 904
DOI 10.1186/s12913-019-4557-4

Publications 2017

Bakke A, Cooper JG, Thue G, Skeie S, Carlsen S, Dalen I, Lovaas KF, Madsen TV, Oord ER, Berg TJ, Claudi T, Tran AT, Gjelsvik B, Jenum AK, Sandberg S (2017)
Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening
BMJ Open Diab. Res. Care, 5 (1), e000459
DOI 10.1136/bmjdrc-2017-000459

Holte KB, Juel NG, Brox JI, Hanssen KF, Fosmark DS, Sell DR, Monnier VM, Berg TJ (2017)
Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study
J. Diabetes Complications, 31 (9), 1408-1414
DOI 10.1016/j.jdiacomp.2017.06.007

Juel NG, Brox JI, Brunborg C, Holte KB, Berg TJ (2017)
Very High Prevalence of Frozen Shoulder in Patients With Type 1 Diabetes of >= 45 Years' Duration: The Dialong Shoulder Study
Arch. Phys. Med. Rehabil., 98 (8), 1551-1559
DOI 10.1016/j.apmr.2017.01.020

Magnusson K, Holte KB, Juel NG, Brox JI, Hagen KB, Haugen IK, Berg TJ (2017)
Long term type 1 diabetes is associated with hand pain, disability and stiffness but not with structural hand osteoarthritis features - The Dialong hand study
PLoS One, 12 (5), e0177118
DOI 10.1371/journal.pone.0177118

Robberstad M, Bentsen SB, Berg TJ, Iversen MM (2017)
Diabetic foot ulcer teams in Norwegian hospitals
Tidsskr. Nor. Laegeforen., 137 (17), 1294-1298

Publications 2014

Strom H, Selmer R, Birkeland KI, Schirmer H, Berg TJ, Jenum AK, Midthjell K, Berg C, Stene LC (2014)
No increase in new users of blood glucose-lowering drugs in Norway 2006-2011: a nationwide prescription database study
BMC Public Health, 14, 520
DOI 10.1186/1471-2458-14-520

Publications 2009

Skrivarhaug T, Fretheim A, Berg TJ, Thorsby PM (2009)
Type 1 - diabetes
In Medisinsk informasjon: kunnskapsbasert helsefaglig oppdatering, MEDLEX Norsk helseinformasjon, Oslo, årg. 23(2009)nr. 1, 31 s.
BIBSYS 091932777, ISBN 978-82-7841-565-8

Publications 2007

Bilous RW, Berg TJ (2007)
Forstå diabetes
Exlibriz, Oslo, 176 s.
BIBSYS 080352243, ISBN 978-82-8173-026-7

Steine K, Larsen JR, Stugaard M, Berg TJ, Brekke M, Dahl-Jorgensen K (2007)
LV systolic impairment in patients with asymptomatic coronary heart disease and type I diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts
Eur. J. Heart Fail., 9 (10), 1044-1050
DOI 10.1016/j.ejheart.2007.07.013

Publications 2004

Larsen JR, Sjøholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, Dahl-Jørgensen K (2004)
Eighteen years of fair glycemic control preserves cardiacautonomic function in type 1 diabetes
In Diabetes care, The Association, Alexandria, VA, 27(2004)4, S. 963-6
BIBSYS 05180686x

Publications 2003

Kilhovd BK, Giardino I, Torjesen PA, Birkeland KI, Berg TJ, Thornalley PJ, Brownlee M, Hanssen KF (2003)
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
In Metabolism, Grune & Stratton, New York, 52(2003)2, s.163-7
BIBSYS 041719271

Larsen JR, Sjøholm H, Hanssen KF, Sandvik K, Berg TJ, Dahl-Jørgensen K (2003)
Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes
In Diabetes care, The Association, Alexandria, VA, 26(2003)8, s.2400-4
BIBSYS 041719344

Svistounov DN, Berg TJ, McCourt PA, Zykova SN, Elvevold K, Nagai R, Horiuchi S, Smedsrød B (2003)
Lack of recognition of Nepsilon-(carboxymethyl)lysine by the mouse liver reticulo-endothelial system: implications for pathophysiology
In Biochemical and biophysical research communications, Academic Press, New York, 309(2003)4, s.786-91
BIBSYS 041726723

Publications 2001

Kilhovd B, Hjerkinn EM, Seljeflot I, Berg TJ, Reikvam AA (2001)
The ACE inhibitor ramipril influences the serum levels ofadvanced glycation endproducts in high risk patients with coronary artery disease: results from a HOPE substudy
In European heart journal, Supplements, Saunders, London, 22(2001)Abstr. suppl, s.27 Abstrakt nr 243
BIBSYS 022034269

Kilhovd B, Hjerkinn EM, Seljeflot I, Berg TJ, Reikvam Å (2001)
Increase in serum levels of advanced glycation endproducts in high risk coronary artery disease patients is modified by the ace inhibitor ramipril
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A319 Abstrakt nr 1226
BIBSYS 02203529x

Prydz K, Fjalestad K, Vuong TT, Berg TJ, Holkov C, Kolset SO, Borrebæk J (2001)
The AGE product N epsilon-(carboxymethyl)lysine serum albumin is a modulator of proteoglycan expression in polarized cultured kidney epithelial cells
In Diabetologia, Springer, Berlin, 44(2001)nr 4, s.488-494
BIBSYS 022030069

Publications 2000

Hanssen KF, Berg TJ (2000)
Diabetesbehandling i forandring
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2001)nr. 20, S. 2377
BIBSYS 022063064

Publications 1998

Berg TJ (1998)
Advanced glycation end products: studies on advanced glycation, oxidation and glycoxidation products in the circulation of patients with type 1 diabetes and their association with micro- and macrovascular complications
Aker Diabetes Research Centre, Department of Endocrinology, Hormone Laboratory, Aker University Hospital, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 990069044, ISBN 82-994853-0-4

Publications 1995

Berg TJ (1995)
Ei håndbok om type 1 diabetes
Norges diabetesforbund, Oslo, 54 s.
BIBSYS 952009005, ISBN 82-90472-07-2

Berg TJ (1995)
En håndbok om type 1 diabetes
Norges diabetesforbund, Oslo, 54 s.
BIBSYS 972943323